Glaucoma in Europe: Epidemiology & Patient Flow Analysis - 2018 - ResearchAndMarkets.com

DUBLIN--()--The "Europe Glaucoma Epidemiology and Patient Flow Analysis - 2018" report has been added to ResearchAndMarkets.com's offering.

The research provides insights into Glaucoma epidemiology, Glaucoma diagnosed patients, and Glaucoma treatment rate for EU5 countries. The research measures key indicators including prevalence of Glaucoma derived from epidemiological analysis, patients diagnosed with Glaucoma, and patients treated with a drug therapy.

The research study helps executives estimate Glaucoma market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.

The research provides estimates and forecasts of Glaucoma prevalence, Glaucoma diagnosis rate, and Glaucoma treatment rate for the period 2017-2026. The information is presented by EU5 countries including Germany, France, Spain, Italy, and UK.

Key Topics Covered

1. Glaucoma: Disease Definition

2. Glaucoma Patient Flow in Europe

3. Glaucoma Patient Flow in Germany

4. Glaucoma Patient Flow in France

5. Glaucoma Patient Flow in Spain

6. Glaucoma Patient Flow in Italy

7. Glaucoma Patient Flow in UK

8. Research Methodology

For more information about this report visit https://www.researchandmarkets.com/research/72tczj/glaucoma_in?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Optical Disorders Drugs

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Optical Disorders Drugs